FDA may authorize COVID-19 vaccine for children by midwinter

Published



The Food and Drug Administration could grant an emergency use authorization for a COVID-19 vaccine for children by midwinter.

Thus far, the FDA has only given COVID-19 vaccines emergency approval for those over age 12. Both Pfizer and Moderna are currently running trials for those under age 12.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.